Published

Penumbra announces completion of THUNDER IDE study enrolment for acute ischemic stroke

Summary by Med-Tech Innovation | Latest News for the Medical Device Industry
Penumbra, Inc., a leading thrombectomy company, has announced the completion of enrolment in its THUNDER clinical study for patients with acute ischemic stroke.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.